Resultats de la cerca - Jack A Schalken
Abans heu d’iniciar sessió
- Mostrar 1 - 18 resultats de 18
-
1
-
2
-
3
-
4
TTLL12 has a potential oncogenic activity, suppression of ligation of nitrotyrosine to the C-terminus of detyrosinated α-tubulin, that can be overcome by molecules identified by sc... per Amit Deshpande, Jan Brants, Christine Wasylyk, Onno van Hooij, Gerald W Verhaegh, Peter Maas, Jack A Schalken, Bohdan Wasylyk
Publicat 2024-01-01
Article -
5
XRP44X, an Inhibitor of Ras/Erk Activation of the Transcription Factor Elk3, Inhibits Tumour Growth and Metastasis in Mice. per Kostyantyn Semenchenko, Christine Wasylyk, Henry Cheung, Yves Tourrette, Peter Maas, Jack A Schalken, Gabri van der Pluijm, Bohdan Wasylyk
Publicat 2016-01-01
Article -
6
Transcriptome Profiling of Circulating Tumor Cells to Predict Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer per Levi Groen, Iris Kloots, David Englert, Kelly Seto, Lana Estafanos, Paul Smith, Gerald W. Verhaegh, Niven Mehra, Jack A. Schalken
Publicat 2023-05-01
Article -
7
-
8
The Androgen Regulated lncRNA <i>NAALADL2-AS2</i> Promotes Tumor Cell Survival in Prostate Cancer per Levi Groen, Viktor Yurevych, Harshitha Ramu, Johnny Chen, Lianne Steenge, Sabrina Boer, Renske Kuiper, Frank P. Smit, Gerald W. Verhaegh, Niven Mehra, Jack A. Schalken
Publicat 2022-12-01
Article -
9
Tubulin tyrosine ligase like 12, a TTLL family member with SET- and TTL-like domains and roles in histone and tubulin modifications and mitosis. per Jan Brants, Kostyantyn Semenchenko, Christine Wasylyk, Aude Robert, Annaick Carles, Alberto Zambrano, Karine Pradeau-Aubreton, Catherine Birck, Jack A Schalken, Olivier Poch, Jan de Mey, Bohdan Wasylyk
Publicat 2012-01-01
Article -
10
-
11
Value of PCA3 to Predict Biopsy Outcome and Its Potential Role in Selecting Patients for Multiparametric MRI per Peter F. A. Mulders, Jack A. Schalken, Jelle O. Barentsz, J. P. Michiel Sedelaar, Jurgen J. Futterer, Inge M. van Oort, Elisabeth A. Wierenga, Gisele H. J. M. Leyten
Publicat 2013-05-01
Article -
12
Androgen receptor signalling confers clonogenic and migratory advantages in urothelial cell carcinoma of the bladder per Maria V. Luna‐Velez, Jelmer J. Dijkstra, Marina A. Heuschkel, Frank P. Smit, Guillaume van de Zande, Dominique Smeets, J. P. Michiel Sedelaar, Michiel Vermeulen, Gerald W. Verhaegh, Jack A. Schalken
Publicat 2021-07-01
Article -
13
A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metast... per Jetty A. M. Weijers, Gerald W. Verhaegh, G. Lassche, Adriana C. H. van Engen-van Grunsven, Chantal M. L. Driessen, Nielka P. van Erp, Marianne A. Jonker, Jack A. Schalken, Carla M. L. van Herpen
Publicat 2024-09-01
Article -
14
Molecular Phenotyping of AR Signaling for Predicting Targeted Therapy in Castration Resistant Prostate Cancer per Agus Rizal A. H. Hamid, Agus Rizal A. H. Hamid, Maria V. Luna-Velez, Aleksandra M. Dudek, Cornelius F. J. Jansen, Frank Smit, Tilly W. Aalders, Gerald W. Verhaegh, Ewout Schaafsma, John P. M. Sedelaar, Jack A. Schalken
Publicat 2021-08-01
Article -
15
Liquid biopsy reveals KLK3 mRNA as a prognostic marker for progression free survival in patients with metastatic castration‐resistant prostate cancer undergoing first‐line abirater... per Emmy Boerrigter, Guillemette E. Benoist, Inge M. vanOort, Gerald W. Verhaegh, Onno vanHooij, Levi Groen, Frank Smit, Irma M. Oving, Pieter deMol, Tineke J. Smilde, Diederik M. Somford, Niven Mehra, Jack A. Schalken, Nielka P. vanErp
Publicat 2021-09-01
Article -
16
The Identification of Small Molecule Inhibitors That Reduce Invasion and Metastasis of Aggressive Cancers per Arjanneke F. van de Merbel, Onno van Hooij, Geertje van der Horst, Cindy C. M. van Rijt-van de Westerlo, Maaike H. van der Mark, Henry Cheung, Jan Kroon, Gerald W. Verhaegh, Johan Tijhuis, Antoine Wellink, Peter Maas, Henk Viëtor, Jack A. Schalken, Gabri van der Pluijm
Publicat 2021-02-01
Article -
17
Urine cell-based DNA methylation classifier for monitoring bladder cancer per Antoine G. van der Heijden, Lourdes Mengual, Mercedes Ingelmo-Torres, Juan J. Lozano, Cindy C. M. van Rijt-van de Westerlo, Montserrat Baixauli, Bogdan Geavlete, Cristian Moldoveanud, Cosmin Ene, Colin P. Dinney, Bogdan Czerniak, Jack A. Schalken, Lambertus A. L. M. Kiemeney, Maria J. Ribal, J. Alfred Witjes, Antonio Alcaraz
Publicat 2018-05-01
Article -
18
Genetic Aspects and Molecular Testing in Prostate Cancer: A Report from a Dutch Multidisciplinary Consensus Meeting per Niven Mehra, Iris Kloots, Michiel Vlaming, Shafak Aluwini, Els Dewulf, Daniela E. Oprea-Lager, Henk van der Poel, Herman Stoevelaar, Derya Yakar, Chris H. Bangma, Elise Bekers, Roderick van den Bergh, Andries M. Bergman, Franchette van den Berkmortel, Steve Boudewijns, Winand N.M. Dinjens, Jurgen Fütterer, Tom van der Hulle, Guido Jenster, Leonie I. Kroeze, Michel van Kruchten, Geert van Leenders, Pim J. van Leeuwen, Wendy W.J. de Leng, R. Jeroen A. van Moorselaar, Walter Noordzij, Rogier A. Oldenburg, Inge M. van Oort, Irma Oving, Jack A. Schalken, Ivo G. Schoots, Ed Schuuring, Robert J. Smeenk, Ben G.L. Vanneste, Erik Vegt, André N. Vis, Kim de Vries, Peter-Paul M. Willemse, Maurits Wondergem, Margreet Ausems
Publicat 2023-03-01
Article